DOI QR코드

DOI QR Code

LDB2 regulates the expression of DLL4 through the formation of oligomeric complexes in endothelial cells

  • Choi, Hyun-Jung (Severance Integrative Research Institute for Cerebral & Cardiovascular Diseases (SIRIC), College of Medicine, Yonsei University) ;
  • Rho, Seung-Sik (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) ;
  • Choi, Dong-Hoon (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) ;
  • Kwon, Young-Guen (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University)
  • 투고 : 2017.07.21
  • 심사 : 2017.09.14
  • 발행 : 2018.01.31

초록

Delta-like ligand 4 (DLL4) expression in endothelial cells is intimately associated with angiogenic sprouting and vascular remodeling, but the precise mechanism of transcriptional regulation of DLL4 remains incompletely understood. Here, we showed that LIM-domain binding protein 2 (LDB2) plays an important role in regulating basal DLL4 and VEGF-induced DLL4 expression. Knockdown of LDB2 using siRNA enhanced endothelial sprouting and tubular network formation in vitro. Injection of ldb2-morpholino resulted in defective development of intersegmental vessels in zebrafish. Reduction or over-expression of LDB2 in endothelial cells decreased or increased DLL4 expression. LDB2 regulated DLL4 promoter activity by binding to its promoter region and the same promoter region was occupied and regulated by the LMO2/TAL1/GATA2 complex. Interestingly, LDB2 also mediated VEGF-induced DLL4 expression in endothelial cells. The regulation of DLL4 by the LDB2 complex provides a novel mechanism of DLL4 transcriptional control that may be exploited to develop therapeutics for aberrant vascular remodeling.

키워드

참고문헌

  1. Blanco R and Gerhardt H (2013) VEGF and Notch in tip and stalk cell selection. Cold Spring Harb Perspect Med 3, a006569
  2. Gridley T (2010) Notch signaling in the vasculature. Curr Top Dev Biol 92, 277-309
  3. Lobov IB, Renard RA, Papadopoulos N et al (2007) Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A 104, 3219-3224 https://doi.org/10.1073/pnas.0611206104
  4. Suchting S, Freitas C, le Noble F et al (2007) The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A 104, 3225-3230 https://doi.org/10.1073/pnas.0611177104
  5. Gerhardt H, Golding M, Fruttiger M et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161,1163-1177 https://doi.org/10.1083/jcb.200302047
  6. Hellstrom M, Phng LK, Hofmann JJ et al (2007) Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780 https://doi.org/10.1038/nature05571
  7. Agulnick AD, Taira M, Breen JJ, Tanaka T, Dawid IB and Westphal H (1996) Interactions of the LIM-domainbinding factor Ldb1 with LIM homeodomain proteins. Nature 384, 270-272 https://doi.org/10.1038/384270a0
  8. Becker T, Ostendorff HP, Bossenz M et al (2002) Multiple functions of LIM domain-binding CLIM/NLI/Ldb cofactors during zebrafish development. Mech Dev 117, 75-85 https://doi.org/10.1016/S0925-4773(02)00178-8
  9. Matthews JM and Visvader JE (2003) LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins. EMBO Rep 4, 1132-1137 https://doi.org/10.1038/sj.embor.7400030
  10. Bach I, Carriere C, Ostendorff HP, Andersen B and Rosenfeld MG (1997) A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins. Genes Dev 11, 1370-1380 https://doi.org/10.1101/gad.11.11.1370
  11. Wadman IA, Osada H, Grutz GG et al (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 16, 3145-3157 https://doi.org/10.1093/emboj/16.11.3145
  12. Song SH, Kim A, Ragoczy T, Bender MA, Groudine M and Dean A (2010) Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation. Blood 116, 2356-2364 https://doi.org/10.1182/blood-2010-03-272252
  13. Bridge G, Monteiro R, Henderson S et al (2012) The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood 120, 5063-5072 https://doi.org/10.1182/blood-2012-04-423004
  14. Mukhopadhyay M, Teufel A, Yamashita T et al (2003) Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation. Development 130, 495-505 https://doi.org/10.1242/dev.00225
  15. Corada M, Nyqvist D, Orsenigo F et al (2010) The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 18, 938-949 https://doi.org/10.1016/j.devcel.2010.05.006
  16. Hayashi H and Kume T (2008) Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS One 3, e2401 https://doi.org/10.1371/journal.pone.0002401
  17. Seo S, Fujita H, Nakano A, Kang M, Duarte A and Kume T (2006) The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev Biol 294, 458-470 https://doi.org/10.1016/j.ydbio.2006.03.035
  18. Wythe JD, Dang LT, Devine WP et al (2013) ETS factors regulate Vegf-dependent arterial specification. Dev Cell 26, 45-58 https://doi.org/10.1016/j.devcel.2013.06.007
  19. Sacilotto N, Monteiro R, Fritzsche M et al (2013) Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development. Proc Natl Acad Sci U S A 110, 11893-11898 https://doi.org/10.1073/pnas.1300805110
  20. Patterson LJ, Gering M and Patient R (2005) Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. Blood 105, 3502-3511 https://doi.org/10.1182/blood-2004-09-3547
  21. Visvader JE, Fujiwara Y and Orkin SH (1998) Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 12, 473-479 https://doi.org/10.1101/gad.12.4.473
  22. Lazrak M, Deleuze V, Noel D et al (2004) The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis. J Cell Sci 117, 1161-1171 https://doi.org/10.1242/jcs.00969
  23. Deleuze V, Chalhoub E, El-Hajj R et al (2007) TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol 27, 2687-2697 https://doi.org/10.1128/MCB.00493-06
  24. Yamada Y, Pannell R, Forster A and Rabbitts TH (2000) The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci U S A 97, 320-324 https://doi.org/10.1073/pnas.97.1.320
  25. Javerzat S, Franco M, Herbert J et al (2009) Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system. PLoS One 4, e7856 https://doi.org/10.1371/journal.pone.0007856
  26. Min JK, Cho YL, Choi JH et al (2007) Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 109, 1495-1502 https://doi.org/10.1182/blood-2006-06-029298
  27. Nakatsu MN and Hughes CC (2008) An optimized three-dimensional in vitro model for the analysis of angiogenesis. Methods Enzymol 443, 65-82
  28. Choi HJ, Zhang H, Park H et al (2015) Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat Commun 6, 6943 https://doi.org/10.1038/ncomms7943
  29. Na HH, Noh HJ, Cheong HM et al (2016) SETDB1 mediated FosB expression increases the cell proliferation rate during anticancer drug therapy. BMB Rep 49, 238-243 https://doi.org/10.5483/BMBRep.2016.49.4.031
  30. Song I, Jeong BC, Choi YJ et al (2016) GATA4 negatively regulates bone sialoprotein expression in osteoblasts. BMB Rep 49, 343-348 https://doi.org/10.5483/BMBRep.2016.49.6.032

피인용 문헌

  1. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma pp.08159319, 2018, https://doi.org/10.1111/jgh.14371